Quick Answer
Yubo International Biotech Ltd reported Total Revenue of $12.4 thousand for fiscal year 2025.
Yubo International Biotech Ltd Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $12.4K | +256.0% |
| 2024 | $3.5K | -99.4% |
| 2023 | $604.7K | +479.8% |
| 2022 | $104.3K | -91.6% |
| 2021 | $1.24M | — |
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
| 2015 | $0.00 | — |
| 2014 | $0.00 | — |
| 2012 | $0.00 | — |
| 2011 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | -100.0% | — |
| September 30, 2024 | $0.00 | -100.0% | — |
| June 30, 2024 | $0.00 | -100.0% | -100.0% |
| March 31, 2024 | $3.5K | -97.8% | -99.2% |
| September 30, 2023 | $428.5K | +2839.0% | +29865.7% |
| June 30, 2023 | $1.4K | -82.1% | -99.1% |
- Yubo International Biotech Ltd showed an increase of +256.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Yubo International Biotech Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: